The role of cardiac surgeons in transcatheter structural heart disease interventions: The evolution of cardiac surgery.

Competing Interests: Conflict of Interest Statement L.P. reported relationships with Edwards Lifesciences Corporation and Medtronic that include speaking and lecture fees. K.G. reported relationships with Medtronic, Abbott, Boston Scientific Corp, 4C Medical Technologies, Ancora Heart, Opsens and that include board membership, consulting or advisory, and speaking and lecture fees. I.G. reported relationships with Zimmer Biomet, AtriCure, Neosurgery, Neptube Medical, Abbvie, J&J, Durvena, Boston Scientific, Edwards Lifesciences, Medtronic, Help-TheraX, 3ive, Encompass, Summus Medical, Abbott, and Xeltis that include consulting or advisory; relationships with Edwards Surgical, Medtronic Structural Mitral & Tricuspid, Trisol Medical, Valcare Medical, Durvena, Abbvie, J&J, Foldax Medical, Zimmer, Neosurgery, Boston Scientific, Summus Medical, and BCI that include board membership; relationships with Valcare Medical, Durvena, Cardiomech, Vdyne, MitreMedical, MITRX, and BCI that include equity or stocks; and relationships with Edwards Lifesciences, Medtronic, Abbott, Boston Scientific, and JenaValve that include funding grants. A.G. reported relationships with Philips, Inari Medical, and Edwards that include consulting or advisory and speaking and lecture fees. T.N. reported relationships with Edwards, Medtronic, Boston Scientific, Opsens Medical, and Encompass that include consulting or advisory and speaking and lecture fees. G.D. reported relationships with Abbott and Edwards that include consulting or advisory and speaking and lecture fees. M.O. reported relationships with Edwards and Artivion that include speaking and lecture fees. W.S. reported relationships with Edwards, Medtronic, Artivion, Abbott, Terumo that include board membership, consulting or advisory, and speaking and lecture fees. F.M. reported relationships with Abbott, Medtronic, Edwards, Biotronik, Boston Scientific, NVT, Terumo, and Venus that include funding grants; relationships with Abbott, Medtronic, Edwards, Xeltis, Cardiovalve, Occlufit, Simulands, Mtex, Venus, Squadra, and Valgen that include consulting or advisory; and relationships with Edwards Lifesciences Corporation, Magenta, Transeptalsolutions, and 4Tech. A.G. reported relationships with Edwards and Medtronic that include consulting or advisory and speaking and lecture fees. T.V. reported relationships with Abbott, Boston Scientific, Edwards, JenaValve, and Medtronic that include funding grants; and relationships with 4C Medical and Philips that include consulting or advisory and speaking and lecture fees. S.K. reported relationships with Admedus, Dura Biotech, TriCares, Phillips, and Triflo that include consulting or advisory and speaking and lecture fees; relationships with Edwards, Medtronic, Abbott, Boston Scientific, and JenaValve that include funding grants; and relationships with Dura Biotech, MicroInterventional Devices, Thubrikar Aortic Valve, Supira, Admedus, TriFlo, Adona, Tioga, and X-Dot that include board membership and equity or stocks. T.K. reported relationships with Edwards, Abbott, and J&J that include board membership; and relationships with Medtronic and CardioMech that include consulting or advisory. G.T. reported relationships with Medtronic and Abbott that include consulting or advisory. P.M. reported no conflicts of interest. The Journal policy requires editors and reviewers to disclose conflicts of interest and to decline handling or reviewing manuscripts for which they may have a conflict of interest. The editors and reviewers of this article have no conflicts of interest.